Time-dependent changes in 18F-FDG activity in the thymus and bone marrow following combination chemotherapy in paediatric patients with lymphoma

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 3, 2010, Pages 462-467

  Goethals, Ingeborg ^a   Hoste, Pieter ^a   De Vriendt, Ciel ^a   Smeets, Peter ^a   Verlooy, Joris ^a   Ham, Hamphrey ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

18F FDG PET CT; Bone marrow; Combination chemotherapy; Lymphoma; Paediatric; Thymus

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LYMPHOMA; MALE; PRESCHOOL CHILD; SCHOOL CHILD; THYMUS; WHOLE BODY PET;

ADOLESCENT; BIOLOGICAL TRANSPORT; BONE MARROW; CHILD; CHILD, PRESCHOOL; CYTOKINES; DRUG THERAPY, COMBINATION; FEMALE; FLUORODEOXYGLUCOSE F18; HEMATOPOIESIS; HUMANS; LYMPHOMA; MALE; RETROSPECTIVE STUDIES; THYMUS GLAND; TIME FACTORS;

EID: 77949262321     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1280-0     Document Type: Article

References (27)

1. BD Cheson 2008 Staging and evaluation of the patient with lymphoma Hematol Oncol Clin North Am 22 825 837 10.1016/j.hoc.2008.07.015 18954739
2. T Terasawa J Lau S Bardet O Couturier T Hotta M Hutchings, et al. 2009 Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review J Clin Oncol 27 1906 1914 10.1200/JCO.2008.16.0861 19273713
3. A Iagaru Y Wang C Mari A Quon ML Goris S Horning, et al. 2008 (18)F-FDG-PET/CT evaluation of response to treatment in lymphoma: when is the optimal time for the first re-evaluation scan? Hell J Nucl Med 11 153 156 19081857
4. C Kobe M Dietlein J Franklin J Markova A Lohri H Amthauer, et al. 2008 Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma Blood 112 3989 3994 10.1182/blood-2008-06-155820 1:CAS:528:DC%2BD1cXhsVSmsrzF 18757777
5. H Schoder C Moskowitz 2008 PET imaging for response assessment in lymphoma: potential and limitations Radiol Clin North Am 46 225 241 10.1016/j.rcl.2008.04.002 18619378 (Pubitemid 351932048)
6. SJ Abramson AP Price 2008 Imaging of pediatric lymphomas Radiol Clin North Am 46 313 338 10.1016/j.rcl.2008.03.009 18619383 (Pubitemid 351934613)
7. M Allen-Auerbach S de Vos J Czernin 2008 The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients Radiol Clin North Am 46 199 211 10.1016/j.rcl.2008.03.004 18619376 (Pubitemid 351932039)
8. B Ferdinand P Gupta EL Kramer 2004 Spectrum of thymic uptake at 18F-FDG PET Radiographics 24 1611 1616 10.1148/rg.246045701 15537971
9. PM Patel H Alibazoglu A Ali E Fordham G LaMonica 1996 Normal thymic uptake of FDG on PET imaging Clin Nucl Med 21 772 775 10.1097/00003072- 199610000-00004 1:STN:280:DyaK2s%2Flt1aruw%3D%3D 8896924 (Pubitemid 26339877)
10. T Nakahara H Fujii M Ide N Nishiumi W Takahashi S Yasuda, et al. 2001 FDG uptake in the morphologically normal thymus: comparison of FDG positron emission tomography and CT Br J Radiol 74 821 824 1:STN:280: DC%2BD3Mrht1yrsg%3D%3D 11560830
11. RL Elstrom DE Tsai JA Vergilio LH Downs A Alavi SJ Schuster 2004 Enhanced marrow [18F]fluorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkin's lymphoma can simulate lymphoma involvement in marrow Clin Lymphoma 5 62 64 10.3816/CLM.2004.n.012 15245610
12. EC Lin 2006 FDG PET/CT flip flop phenomenon in treated lymphoma of bone Clin Nucl Med 31 803 805 10.1097/01.rlu.0000246858.03018.0c 17117078 (Pubitemid 44789563)
13. T Kazama N Swanston DA Podoloff HA Macapinlac 2005 Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow Eur J Nucl Med Mol Imaging 32 1406 1411 10.1007/s00259-005-1890-0 1:CAS:528:DC%2BD2MXht1ygu77O 16133379 (Pubitemid 41746844)
14. Y Sugawara SJ Fisher KR Zasadny PV Kison LH Baker RL Wahl 1998 Preclinical and clinical studies of bone marrow uptake of fluorine-1- fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy J Clin Oncol 16 173 180 1:CAS:528:DyaK1cXmtlOksQ%3D%3D 9440740
15. WJ Yao CK Hoh RA Hawkins JA Glaspy JA Weil SJ Lee, et al. 1995 Quantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines J Nucl Med 36 794 799 1:STN:280:DyaK2M3ls12ksA%3D%3D 7738650
16. MV Knopp H Bischoff A Rimac F Oberdorfer G van Kaick 1996 Bone marrow uptake of fluorine-18-fluorodeoxyglucose following treatment with hematopoietic growth factors: initial evaluation Nucl Med Biol 23 845 849 10.1016/0969- 8051(96)00085-6 1:CAS:528:DyaK28XmsFWmur0%3D 8940729 (Pubitemid 26342490)
17. SC Kaste SC Howard EB McCarville MJ Krasin PG Kogos MM Hudson 2005 18F-FDG-avid sites mimicking active disease in pediatric Hodgkin's Pediatr Radiol 35 141 154 10.1007/s00247-004-1340-3 15654605 (Pubitemid 40124565)
18. I Brink MJ Reinhardt S Hoegerle C Altehoefer E Moser EU Nitzsche 2001 Increased metabolic activity in the thymus gland studied with 18F-FDG PET: age dependency and frequency after chemotherapy J Nucl Med 42 591 595 1:STN:280:DC%2BD3MvkvVGjsg%3D%3D 11337547
19. T Kawano A Suzuki A Ishida N Takahashi J Lee Y Tayama, et al. 2004 The clinical relevance of thymic fluorodeoxyglucose uptake in pediatric patients after chemotherapy Eur J Nucl Med Mol Imaging 31 831 836 10.1007/s00259-004- 1466-4 1:CAS:528:DC%2BD2cXksVensLk%3D 14963698
20. M Daube-Witherspoon S Matej J Karp R Lewitt 2001 Application of the row action maximum likelihood algorithm with spherical basis functions to clinical PET imaging IEEE Trans Nucl Sci 48 24 30 10.1109/23.910827 (Pubitemid 32325598)
21. NR Bogot LE Quint 2005 Imaging of thymic disorders Cancer Imaging 5 139 149 10.1102/1470-7330.2005.0107 16361143
22. MM Hudson MJ Krasin SC Kaste 2004 PET imaging in pediatric Hodgkin's lymphoma Pediatr Radiol 34 190 198 10.1007/s00247-003-1114-3 14745528 (Pubitemid 38396972)
23. CS Smith H Schoder HW Yeung 2007 Thymic extension in the superior mediastinum in patients with thymic hyperplasia: potential cause of false-positive findings on 18F-FDG PET/CT AJR Am J Roentgenol 188 1716 1721 10.2214/AJR.06.0552 17515398 (Pubitemid 46866880)
24. EE Pakos AD Fotopoulos JP Ioannidis 2005 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis J Nucl Med 46 958 963 15937306
25. S Gundlapalli B Ojha JM Mountz 2002 Granulocyte colony-stimulating factor: confounding F-18 FDG uptake in outpatient positron emission tomographic facilities for patients receiving ongoing treatment of lymphoma Clin Nucl Med 27 140 141 10.1097/00003072-200202000-00018 11786751 (Pubitemid 34075881)
26. MP Corder PR Jochimsen 1982 Marrow neutrophil reserve after adjuvant chemotherapy for carcinoma of the breast Cancer 49 2455 2458 10.1002/1097-0142(19820615)49:12<2455::AID-CNCR2820491206>3.0.CO;2-4 1:STN:280:DyaL387osVWisQ%3D%3D 7074560
27. RV Gardner C Lerner CM Astle DE Harrison 1993 Assessing permanent damage to primitive hematopoietic stem cells after chemotherapy using the competitive repopulation assay Cancer Chemother Pharmacol 32 450 454 10.1007/BF00685889 1:CAS:528:DyaK2cXht1eqtbg%3D 8258193